Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests. 2000

G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
Presidio per la Prevenzione Oncologica, Azienda Ospedaliera Careggi, Florence, Italy. cspo@ats.it

OBJECTIVE To compare two immunochemical faecal occult blood tests based on reversed passive haemagglutination (RPHA) or latex agglutination (Hdia) in a population based screening setting. METHODS Hdia was interpreted according to three positivity thresholds: 100, 150, or 200 ng of haemoglobin/mg of specimen solution. A total of 5844 subjects were recruited into the study, from 17432 invited subjects aged 50-70. RESULTS Positivity rates were 3.3% for RPHA, Hdia100 3.5%, Hdia150 2.5%, Hdia200 2.0%. Among subjects complying with the diagnostic work up, colorectal cancer (CRC) was detected in 19 subjects (17 RPHA positive, 16 Hdia100 positive, 15 Hdia150 positive, 14 Hdia200 positive) and high risk adenoma/s in 41 subjects (28 RPHA positive, 32 Hdia100 positive, 29 Hdia150 positive, 25 Hdia200 positive). The prevalence of screen positive CRC in the population was for RPHA 2.9 per thousand, Hdia100 2.7 per thousand, Hdia150 2.6 per thousand, Hdia200 2.4 per thousand. The prevalence of screen positive high risk adenomas in the population was for RPHA 4.8 per thousand, Hdia100 5.5 per thousand, Hdia150 5.0 per thousand, Hdia200 4.3 per thousand. CONCLUSIONS Hdia100 was as sensitive as RPHA for cancer and high risk adenomas. As Hdia is less technically complex than RPHA, it is a valid alternative to the latter, provided that full automation of the development procedure is available. Increasing the positivity threshold of Hdia up to 150 or 200 ng of haemoglobin/mg of specimen solution is not advisable as the increase in specificity is too small to justify the corresponding decrease in the detection of screen positive cancers in the population.

UI MeSH Term Description Entries
D007841 Latex Fixation Tests Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed) Latex Agglutination Tests,Agglutination Test, Latex,Agglutination Tests, Latex,Fixation Test, Latex,Fixation Tests, Latex,Latex Agglutination Test,Latex Fixation Test,Test, Latex Agglutination,Test, Latex Fixation,Tests, Latex Agglutination,Tests, Latex Fixation
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009780 Occult Blood Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood. Fecal Occult Blood Test,Blood, Occult
D005260 Female Females
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
December 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
June 1992, British journal of cancer,
G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
February 2015, The Medical journal of Malaysia,
G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
August 2005, Australian and New Zealand journal of public health,
G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
January 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
November 2012, European journal of cancer (Oxford, England : 1990),
G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
April 1985, Australian family physician,
G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
October 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
July 2010, Journal of gastroenterology,
G Castiglione, and M Zappa, and G Grazzini, and T Rubeca, and P Turco, and C Sani, and S Ciatto
December 1999, Australian and New Zealand journal of medicine,
Copied contents to your clipboard!